Literature DB >> 27557776

[Gold as an alternative in the treatment of RA patients with malignancies].

Oliver Sander1, Rolf Rau2, Matthias Schneider3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27557776     DOI： 10.1007/s00393-016-0195-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  19 in total

1.  Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.

Authors:  O Sander; G Herborn; E Bock; R Rau
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

2.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

3.  Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.

Authors:  Jing-jing Liu; Qing Liu; Hu-lai Wei; Juan Yi; Huai-shun Zhao; Li-ping Gao
Journal:  Pharmazie       Date:  2011-06       Impact factor: 1.267

4.  Long-term treatment of destructive rheumatoid arthritis with methotrexate.

Authors:  R Rau; B Schleusser; G Herborn; T Karger
Journal:  J Rheumatol       Date:  1997-10       Impact factor: 4.666

5.  Rational design of a comprehensive cancer therapy platform using temperature-sensitive polymer grafted hollow gold nanospheres: simultaneous chemo/photothermal/photodynamic therapy triggered by a 650 nm laser with enhanced anti-tumor efficacy.

Authors:  Xiaoran Deng; Yinyin Chen; Ziyong Cheng; Kerong Deng; Ping'an Ma; Zhiyao Hou; Bei Liu; Shanshan Huang; Dayong Jin; Jun Lin
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

6.  Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.

Authors:  R Peltomaa; L Paimela; H Kautiainen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

7.  Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died.

Authors:  R Myllykangas-Luosujärvi; K Aho; H Isomäki
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

Review 8.  [Medication treatment of rheumatoid arthritis with a history of malignancy. Epidemiological data].

Authors:  M Schmalzing; A Strangfeld; H-P Tony
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

9.  Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.

Authors:  J De La Mata; F J Blanco; J J Gómez-Reino
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

10.  THE INFLUENCE OF VARIOUS SUBSTANCES ON THE GROWTH OF MOUSE CARCINOMA.

Authors:  M S Fleisher; L Loeb
Journal:  J Exp Med       Date:  1914-11-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.